ArticlemSphere2021

Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals.

Debora Stelitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.